US Patient At Home Testing Kits Market Size, Share, Trend and Forecast 2026 | TechSci Research

1
PUBLISHED SEPTEMBER 2021
2016 2026
United States Patient At Home Testing Kits Market
FORECAST AND OPPORTUNITIES
www.techsciresearch.com
MARKET INTELLIGENCE . CONSULTING
1
2

• Table of Contents

S. No. Contents Contents Contents
1. Product Overview Product Overview Product Overview
2. Research Methodology Research Methodology Research Methodology
3. Impact of COVID-19 on United States Patient At Home Testing Kits Market Impact of COVID-19 on United States Patient At Home Testing Kits Market Impact of COVID-19 on United States Patient At Home Testing Kits Market
4. Executive Summary Executive Summary Executive Summary
5. Voice of Customer Voice of Customer Voice of Customer
5.1. Brand Awareness Brand Awareness
5.2. Preferences of At Home Testing Products Across Gender Preferences of At Home Testing Products Across Gender
5.3. Sources of Information Sources of Information
5.4. Factors Influencing Purchase Decision for At Home Testing Kits Factors Influencing Purchase Decision for At Home Testing Kits
6. United States Patient At Home Testing Kits Market Outlook, 2016-2026F United States Patient At Home Testing Kits Market Outlook, 2016-2026F United States Patient At Home Testing Kits Market Outlook, 2016-2026F
6.1. Market Size Forecast Market Size Forecast
6.1.1. By Value
6.2. Market Share Forecast Market Share Forecast
6.2.1. By Test Type (Blood Glucose Testing, Pregnancy Fertility Testing, Cholesterol Testing, Urinanalysis, COVID-19 Testing, Others)
6.2.2. By Sample (Blood, Urine, Saliva/Swab)
6.2.3. By Usage (Disposable v/s Reusable)
6.2.4. By Distribution Channel (Retail Stores, Hypermarket/Supermarket, E-Commerce)
6.2.5. By Region
6.2.6. By Company (2020)
6.3. Market Map Market Map
6.3.1. By Usage
6.3.2. By Distribution Channel
2
3

• Table of Contents

S. No. Contents Contents Contents
7. United States Disposable Patient At Home Testing Kits Market Outlook, 2016-2026F United States Disposable Patient At Home Testing Kits Market Outlook, 2016-2026F United States Disposable Patient At Home Testing Kits Market Outlook, 2016-2026F
7.1. Market Size Forecast Market Size Forecast
7.1.1. By Value
7.2. Market Share Forecast Market Share Forecast
7.2.1. By Test Type (Blood Glucose Testing, Pregnancy Fertility Testing, Cholesterol Testing, Urinanalysis, COVID-19 Testing, Others)
7.2.2. By Sample (Blood, Urine, Saliva/Swab)
7.2.3. By Distribution Channel (Retail Stores, Hypermarket/Supermarket, E-Commerce)
8. United States Reusable Patient At Home Testing Kits Market Outlook, 2016-2026F United States Reusable Patient At Home Testing Kits Market Outlook, 2016-2026F United States Reusable Patient At Home Testing Kits Market Outlook, 2016-2026F
8.1. Market Size Forecast Market Size Forecast
8.1.1. By Value
8.2. Market Share Forecast Market Share Forecast
8.2.1. By Test Type (Blood Glucose Testing, Pregnancy Fertility Testing, Cholesterol Testing, Urinanalysis, COVID-19 Testing, Others)
8.2.2. By Sample (Blood, Urine, Saliva/Swab)
8.2.3. By Distribution Channel (Retail Stores, Hypermarket/Supermarket, E-Commerce)
9. Market Dynamics Market Dynamics Market Dynamics
9.1. Drivers Drivers
9.2. Challenges Challenges
10. Market Trends and Developments Market Trends and Developments Market Trends and Developments
11. Policy and Regulatory Landscape Policy and Regulatory Landscape Policy and Regulatory Landscape
12. Import-Export Analysis Import-Export Analysis Import-Export Analysis
13. United States Economic Profile United States Economic Profile United States Economic Profile
3
4

• Table of Contents

S. No. Contents Contents Contents
14. Competitive Landscape Competitive Landscape Competitive Landscape
14.1. Competition Outlook Competition Outlook
14.2. Company Profiles Company Profiles
14.2.1. Lucira Health Inc.
14.2.2. Essenlix Corporation
14.2.3. Abbott Laboratories, Inc.
14.2.4. Roche Diagnostics Corporation
14.2.5. Siemens Medical Solutions USA, Inc.
14.2.6. Thermo Fischer Scientific, Inc.
14.2.7. Scanwell Health, Inc.
14.2.8. Quidel Corporation
14.2.9. GE Healthcare,Inc.
14.2.10. ACON Laboratories, Inc.
15. Strategic Recommendations Strategic Recommendations Strategic Recommendations
16. About Us Disclaimer About Us Disclaimer About Us Disclaimer
4
5
Product Overview
6

• Scope of Report
• Product of Interest (POI) Patient at Home
  Testing Kits

Diagnostics include various practices or
techniques used for different diseases or
conditions which explain a patients symptoms and
signs. Home Testing can be elucidated as the
tests available for home use. The home testing
boom began in 1970s with pregnancy tests. The
patient at home testing kits can be used based
upon two components, i.e., self test for
screening purpose and self test for monitoring
purpose. These tests can be purchased online or
in pharmacies and are performed without input
from healthcare professionals. Samples taken are
either processed at home or sent to a laboratory,
and may offer screening, diagnosis, monitoring,
or information about the risk of a disease. These
tests are likely to generate additional primary
care consultations as they become more widely
available.
Market Segmentation

BY USAGE
BY TEST TYPE
UNITED STATES PATIENT AT HOME TESTING MARKET

• Reusable
• Disposable

• Blood Glucose Testing
• Pregnancy and Fertility Testing
• Cholesterol Testing
• Urinanalysis
• COVID-19 Testing
• Others

BY DISTRIBUTION CHANNEL

• Retail Stores
• Hypermarkets/Supermarkets
• E-Commerce

BY SAMPLE
BY REGION

• Blood
• Urine
• Saliva/Swab
• Others

• South
• Mid-West
• West
• North-East

6
7
Research Methodology
8

• Research Methodology

Market Profiling
Data Analysis
Data Collection
Data Validation
Developing list of respondents
Formulating Questionnaire
In-depth secondary research was conducted to
determine top players in the United States
Patient at Home Testing Kits Market, overall
market size and segmental market size.
The data was scrutinized using MS-Excel,
statistical tools and internal proprietary
database to obtain qualitative and quantitative
insights about the United States Patient at Home
Testing Kits Market.
Data obtained as a result of primary and
secondary research was validated through rigorous
triangulation.
TechSci conducted interviews with industry
experts and industry players for data collection
and verification.
In order to conduct industry experts interviews,
TechSci formulated a detailed discussion guide.
List of industry players and industry specialists
was developed.
Primary Research
Desk Research
Company Analysis

• Recent Developments
• Market Changing Aspects/Dynamics
• Government Policies
• Final Conclusion

• Market Participants
• Key Strengths

• Identifying Key Opinion Leaders
• Questionnaire Design
• In-depth Interviews

8
9

• Research Methodology

• Baseline Methodology
• Our dedicated team of industry experts has
  monitored and analyzed various aspects of the
  United States Patient at Home Testing Kits
  Market. The team has analyzed the outlook of
  various segments of this market, while
  considering the major influencing factors such as
  hassle-free process, cost effectiveness,
  convenience, among others. The study includes
  market forecasting, which would enable our
  clients to take better decisions while planning
  their strategy to achieve sustainability in the
  United States Patient at Home Testing Kits
  Market.
• Methodology Followed for Calculation of Market
  Size
• Market Size by Value Market size, in terms of
  value, for the year 2020 was calculated based on
  information collected through exhaustive
  secondary research and primary surveys, with
  various key opinion leaders/stakeholders, such as
  Home Testing Kits provider companies, channel
  partners, end users, industry experts, and other
  industry participants.
• The team interviewed more than 15-20 Home Testing
  Kits provider companies, 300 end users, and 10
  industry experts and other value chain
  stakeholders in the United States Patient at Home
  Testing Kits Market to obtain the overall market
  size from 2016 to 2020, which was validated by
  the Delphi technique. Taking standard deviation
  into consideration, the market size was averaged
  out, to arrive at the market size data during
  2016-2020.

9
10

• Research Methodology

• Respondents were asked about the current and
  future market growth rates, market shares by test
  type, by sample, by usage, by distribution
  channel, by region and by company. Removing the
  outlier responses, the geometric mean of growth
  estimates and category wise revenue shares
  generated across various segments were
  considered, to arrive at the final revenue
  shares. Revenue shares generated across various
  segments were further triangulated from other
  stakeholders.
• Methodology Followed for Calculation of Market
  Shares
• Market shares by test type, by sample, by usage,
  by distribution channel, by region and by company
  were calculated based on the responses received
  through primary surveys with industry experts, in
  which the respondents were asked about the market
  shares or revenue generated from various segments
  of the United States Patient at Home Testing Kits
  Market. The final shares were calculated by
  taking the geometric mean of the responses
  gathered from key opinion leaders after
  eliminating the outliers.
• Methodology Followed for Forecasting
• TechSci Research performed periodical checks on
  data collected through the surveys with logic
  checks and analyzed the survey results in
  SPSS/Tableau Software.
• Data triangulation techniques were applied to
  fill the gaps and to present a more meaningful
  picture of the market. To forecast the United
  States Patient at Home Testing Kits Market,
  TechSci Research used various forecast techniques
  such as
• Moving Average
• Time Series Analysis
• Regression Analysis
• Econometric and Judgmental Analysis

10
11

• Research Methodology

TechSci Research used its own forecast tool,
which is based on the growth of various allied
industries in respective regions. TechSci
Research also used the impact analysis during
short, medium and long term period to estimate
the demand and to reach accurate market numbers.
It should be noted that the figures compiled in
the report are only for the organized market
including market share data.
Partial List of Companies Interviewed Key Secondary Sources
Lucira Health Inc. Essenlix Corporation Abbott Laboratories, Inc. Roche Diagnostics Corporation Siemens Medical Solutions USA, Inc. Thermo Fischer Scientific, Inc. Scanwell Health, Inc. Quidel Corporation GE Healthcare, Inc. ACON Laboratories, Inc. World Bank TechSci Research Proprietary Database Knowledge Repository Company Annual Reports Industry Magazines Industry Reports Food and Drug Administration (FDA) Credible Paid Databases International Diabetes Foundation United Health Foundation Centers for Disease Control and Prevention
11
12

• Industry Brief

Growing adoption of DIY (Do-it-Yourself) testing
and diagnostics concept is expected to drive the
growth of United States patient at home testing
kits market. According to TechSci report on,
United States Patient At Home Testing Kits
Market By Test Type (Blood Glucose Testing,
Pregnancy Fertility Testing, Cholesterol
Testing, Urine Testing, COVID-19 Testing,
Others), By Sample (Blood, Urine, Saliva), By
Usage (Disposable v/s Reusable), By Distribution
Channel (Retail Pharmacy Stores,
Hypermarket/Supermarket, E-Commerce) By Region,
Competition Forecast Opportunities, 2026,
United States patient at home testing kits market
stood at USD3239.54 million and is expected to
grow at a CAGR of 7.94 during the forecast
period. The growing healthcare awareness among
the population about the prevalence, causes,
symptoms, diagnosis and treatment of different
diseases is expected to fuel the growth of the
United States patient at home testing kits
market. The population in the country has become
quite conscious and aware about different
diseases and a paradigm shift has been observed
in the behavior of the general population towards
preventive healthcare rather than curative
healthcare. This will certainly increase the
demand for at home testing kits in the coming
years. Additionally, the growing prevalence of
chronic diseases such as cardiovascular diseases
and diabetes is expected to support the market
growth through 2026. United States is home to the
worlds third largest diabetic population. Around
30.3 million adults in the United States are
suffering from diabetes which is almost 1 in 10
adults. Cardiovascular diseases are the leading
cause of death in the United States, with around
659,041 reported deaths in 2019. The major
factors contributing to cardiovascular diseases
in the United States are diabetes and high
cholesterol. This in turn is expected to increase
the demand for blood glucose testing and
cholesterol testing segment of patient at home
testing kits market. However, it has been
observed that although the patient at home
testing kits are convenient, easy to use and
deliver rapid results but sometimes the results
of these tests are not correct, i.e., the
diagnosis done by these testing kits is not
correct. This is very commonly observed in case
of pregnancy/fertility testing kits wherein false
positive or false negative results are generated.
This in turn leads to reliability constraints
among the users and they prefer going to the
doctor at early stages only rather than taking
self-tests at home. United States patient at home
testing kits market can be segmented into test
type, sample, usage, distribution channel, region
and company. Based on sample, the United States
patient at home testing kits market can be
categorized into blood, urine and saliva. The
blood sample segment dominated the market in 2020
with a share of around 44.50 and will continue
to maintain its dominance in the forecast period
as well since blood samples are used to perform
majority of patient at home diagnostic tests
including blood glucose monitoring, HIV testing,
prothrombin test, among others. However, the
share for saliva significantly increased in 2021
on account of their widespread use in at home
COVID-19 testing. While the urine samples are
majorly used in pregnancy/fertility testing and
urine analysis. By usage, the United States
patient at home testing kits market can be
segmented into disposable kits and reusable kits.
Disposable kits hold a larger share in the
patient at home testing kit market and will
continue to grow in the forecast period. The
reason for the uninterrupted demand for
disposable kit will directly depend on their
consumer behavior. Most of the self- diagnostic
tests, which primarily include sources like
saliva, urine testing which require disposable
kits. Moreover, increasing awareness regarding
health and hygiene after COVID-19 outbreak is one
of the leading factors to use disposable kits,
only to prevent the further spread of infection.
Diagnostic tests done by reusable kits are
disease specific and require more attention while
handling as compared to disposable kits. Major
players operating in the United States patient at
home testing kits market include Lucira Health
Inc., Essenlix Corporation, Abbott Laboratories,
Inc., Roche Diagnostics Corporation, Siemens
Medical Solutions USA, Inc., Thermo Fischer
Scientific, Inc., Scanwell Health, Inc., Quidel
Corporation, GE Healthcare, Inc., ACON
Laboratories, Inc., among others. The growing
adoption of telemedicine and remote patient
monitoring in the United States has significantly
increased the demand for patient at home testing
kits. Additional advancements such as use of
digital pregnancy kits, pregnancy strip
self-test, among others are further expected to
support the market growth through 2026., said
Mr. Karan Chechi, Research Director with TechSci
Research, a research based global management
consulting firm.
12
13

• Sample Data - Snapshot

United States Patient At Home Testing Kits Market
Size, By Value (USD Million), 2016-2026F
CAGR 2016-2020 By Value xx
CAGR 2021E-2026F By Value xx
United States Disposable Patient At Home Testing
Kits Market Share, By Test Type, By Value,
2016-2026F
United States Reusable Patient At Home Testing
Kits Market Share, By Sample, By Value, 2016-2026F
13
14

• Report Ordering

• Report Name United States Patient At Home
  Testing Kits Market
• FORECAST AND OPPORTUNITIES
• 2016 2026

License Type Price
Single User License 3500
Multi-User License 4500
Custom Research License 7500
To View Sample OR Purchase Report  
14
15
About Us Disclaimer
TechSci Research is a global market research and
consulting company with offices in the US, UK and
India. TechSci Research provides market research
reports in number of areas to organizations. The
company uses innovative business models that
focus on improving productivity, while ensuring
creation of high-quality reports. The proprietary
forecasting models use various analyses of both
industry-specific and macroeconomic variables on
a state-by-state basis to produce a unique
bottom-up model of a country, regional and
global industry prospects. Combined with the
detailed analysis of company activity and
industry trends, the result is a uniquely rich
evaluation of the opportunities available in the
market.
Related Reports

• United States Diagnostics Market, By Product Type
  (Reagents, Instruments, Software Services), By
  Type of Test (Infectious Disease Testing, Lipid
  Panel, Metabolic Panel, Others), By Technique
  (Immunodiagnostics, Clinical Techniques,
  Molecular Diagnostics, Tissue Diagnostics,
  Others), By Usability (Reusable v/s Disposable),
  By Application (Infectious Diseases (Human
  Papillomavirus, Hepatitis, Tuberculosis,
  Hospital-Acquired Infections, COVID-19), Cancer,
  Sexually Transmitted Diseases, Others), By End
  User (Hospitals, Public labs, Diagnostic Centers,
  Point-of-Care Testing Centers, Private or
  Commercial Laboratories, Others), By Region,
  Competition Forecast Opportunities, 2026
• United States Precision Medicine Market, By
  Products and Services (Precision Medicine
  Platforms, Precision Medicine Tools, Precision
  Medicine Services) By Technology (Big Data
  Analytics, Artificial Intelligence,
  Bioinformatics, Whole Genome Sequencing,
  Companion Diagnostics, Next Generation Sequencing
  (NGS), Others) By Application (Oncology,
  Immunology, Cardiology, Neurology, Respiratory,
  Others) By End-User (Pharmaceutical and
  Biotechnology Companies, Healthcare IT,
  Diagnostic Companies, Clinical Research
  Organization, Research Institutes) By Company, By
  Region, Forecast Opportunities, 2026

TechSci Research North America 708 Third
Avenue, Manhattan, New York, United States Tel
1- 646- 360- 1656 Email sales_at_techsciresearch.co
m www.techsciresearch.com
TechSci Research Europe 54, Old brook,
Bretton, Peterborough, United Kingdom Email
sales_at_techsciresearch.com www.techsciresearch.com
TechSci Research Asia-Pacific B 44, Sector
57, Noida, National Capital Region, U.P. -
India Tel [phone] Email
sales_at_techsciresearch.com www.techsciresearch.com
Disclaimer
The contents of this report are based on
information generally available to the public
from sources believed to be reliable. No
representation is made that it is timely,
accurate or complete. TechSci Research has taken
due care and caution in compilation of data as
this has been obtained from various sources
including which it considers reliable and first
hand. However, TechSci Research does not
guarantee the accuracy, adequacy or completeness
of any information and it is not responsible for
any errors or omissions or for the results
obtained from the use of such information and
especially states that it has no financial
liability whatsoever to the subscribers / users
of this report. The information herein, together
with all estimates and forecasts, can change
without notice. All the figures provided in this
document are indicative of relative market size
and are strictly for clients internal
consumption. Usage of the same for purpose other
than internal will require prior approval of
TechSci Research.